S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel

India to resume exports of coronavirus vaccines in October

Monday, September 20, 2021 | Sheikh Saaliq And Aniruddha Ghosal, Associated Press


FILE- In this Jan. 21, 2021, file photo, employees pack boxes containing vials of Covishield, a version of the AstraZeneca vaccine at the Serum Institute of India in Pune, India. India, the world's largest vaccine producer, says it will resume exports and donations of surplus coronavirus vaccines in October after halting them during a devastating surge in domestic infections in April. (AP Photo/Rafiq Maqbool, File)

NEW DELHI (AP) — India, the world's largest vaccine producer, will resume exports and donations of surplus coronavirus vaccines in October after halting them during a devastating surge in domestic infections in April, the health minister said Monday.

Mansukh Mandaviya said the surplus vaccines will be used to fulfill India's "commitment towards the world for the collective fight against COVID-19,” but vaccinating Indians will remain the government's "topmost priority.”

India was expected to be a key supplier for the world and for the U.N.-backed initiative aimed at vaccine equity known as COVAX. It began exporting doses in January but stopped doing so to inoculate its own population during a massive surge in infections in April that pushed India’s health system to the breaking point.

The halt in exports left many developing countries without adequate supplies and delayed vaccines for millions of people.

Before halting exports, India donated or sold 66 million vaccine doses to nearly 100 countries.

Mandaviya did not specify how many doses would be exported. He said India's monthly coronavirus vaccine production has more than doubled since April and is expected to increase to 300 million doses in October.

“We will help the world and fulfil our responsibility to COVAX,” he said.

Serum Institute of India, the world’s largest maker of vaccines, is now producing an estimated 150 million doses of the AstraZeneca vaccine each month, a more than twofold increase since April.

India’s inoculations have risen in recent months.

A country of nearly 1.4 billion people, India has administered more than 800 million vaccine doses. It has given at least one dose to more than 62% of the eligible adult population and two doses to about 22%.


7 Solar Stocks That Are Ready to Shine

Investors have been frustrated by the renewable energy sector for decades. One reason for that is the technology was not ready for prime time, at least not in a cost-effective way. That is changing rapidly and with it the opportunity to be found in renewable energy stocks. However, within the renewable energy sector, wind and solar remain on top of the pyramid. The focus of this unique presentation is on solar stocks that are ready to break out.

Yes, President Biden’s infrastructure plan could have a significant impact on the sector. But interest in solar power has been growing for several years. One reason is that it’s become a national play. Solar used to be limited to areas like California and Florida, but improvements in the efficiency of the technology and the ability to capture the power for future use make it a viable option in more areas of the country. As evidence of this, the total amount of solar capacity installed throughout the country can power approximately 18 million homes.

As renewable energy options continue to expand, so will the opportunity for growth in solar. This is the beginning of what stands to be a multi-year trend. And there’s no time like the present for opportunistic investors to get involved.

View the "7 Solar Stocks That Are Ready to Shine".


Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.